How are necroptosis, immune dysfunction, and motoneuron death connected in amyotrophic lateral sclerosis?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuroimmunology and Neuroinflammation

• Publication date

  2017-06-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.20517/2347-8659.2017.12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice

  2017cited by this paper
• Necroptosis in amyotrophic lateral sclerosis and other neurological disorders.

  2017cited by this paper
• RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS

  2016influential reference
• Th17 Cell Response in SOD1G93A Mice following Motor Nerve Injury

  2016cited by this paper
• In-situ expression of Interleukin-18 and associated mediators in the human brain of sALS patients: Hypothesis for a role for immune-inflammatory mechanisms.

  2016cited by this paper
• Activation of necroptosis in multiple sclerosis.

  2015cited by this paper
• Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

  2015cited by this paper
• TDP-43 activates microglia through NF-κB and NLRP3 inflammasome.

  2015cited by this paper
• SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

  2014cited by this paper
• Necroptosis drives motor neuron death in models of both sporadic and familial ALS.

  2014cited by this paper
• Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.

  2014cited by this paper
• Absence of receptor interacting protein kinase 3 prevents ethanol‐induced liver injury

  2013cited by this paper
• Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis

  2013cited by this paper
• Amyotrophic lateral sclerosis: Problems and prospects

  2013cited by this paper
• Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

  2013cited by this paper
• Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.

  2012cited by this paper
• Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.

  2012cited by this paper
• Immunological Aspects in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival

  2012cited by this paper
• DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

  2012cited by this paper
• The flick of a switch: which death program to choose?

  2012cited by this paper
• IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection.

  2011cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• RIP3 mediates the embryonic lethality of caspase-8-deficient mice

  2011cited by this paper
• Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present

  2011cited by this paper
• The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

  2011cited by this paper
• Programmed necrosis from molecules to health and disease.

  2011cited by this paper
• cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms

  2011cited by this paper
• TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations.

  2011cited by this paper
• Necroptosis as an alternative form of programmed cell death.

  2010cited by this paper
• Interleukin‐17 and interleukin‐23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?

  2010cited by this paper
• Fas-associated death domain (FADD) is a negative regulator of T-cell receptor–mediated necroptosis

  2010cited by this paper
• IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients

  2010cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

  2009cited by this paper
• Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis

  2009cited by this paper
• Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation.

  2008cited by this paper
• Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.

  2008cited by this paper
• Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice

  2008cited by this paper
• T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS

  2008cited by this paper
• TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

  2008cited by this paper
• Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

  2008influential reference
• Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.

  2008cited by this paper
• Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model

  2007cited by this paper
• Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia

  2007cited by this paper
• Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

  2007cited by this paper
• Absence of Tumor Necrosis Factor-α Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations

  2006cited by this paper
• A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia

  2006cited by this paper
• Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

  2005cited by this paper
• Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis.

  2005cited by this paper
• Integrative role of cPLA2 with COX‐2 and the effect of non‐steriodal anti‐inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis

  2005cited by this paper
• Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players.

  2005cited by this paper
• Apoptosis in amyotrophic lateral sclerosis--what is the evidence?

  2005cited by this paper
• Unraveling the mechanisms involved in motor neuron degeneration in ALS.

  2004cited by this paper
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004cited by this paper
• The facial nerve axotomy model.

  2004cited by this paper
• Occurrence of amyotrophic lateral sclerosis among Gulf War veterans

  2003cited by this paper
• Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

  2002cited by this paper
• Premorbid weight, body mass, and varsity athletics in ALS

  2002cited by this paper
• Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.

  2002cited by this paper
• Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.

  2000cited by this paper
• Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases

  2000cited by this paper
• Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism.

  1999cited by this paper
• Familial amyotrophic lateral sclerosis.

  1997cited by this paper
• Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation

  1994cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Mild ALS in Japan associated with novel SOD mutation

  1993cited by this paper
• Evidence for autoimmunity in amyotrophic lateral sclerosis.

  1993cited by this paper
• Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis.

  1986cited by this paper

• Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

  2020cites this paper
• A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1G93A Rats

  2019cites this paper